MindSetting Institute

MindSetting Institute is a Canadian mental health and psychedelic-enhanced psychotherapy organization focused on patient-centred counselling, therapist-guided psychedelic therapy, and clinician training. The company developed the proprietary TRIP Protocol, an evidence-based five-step model for active therapist participation before, during, and after psychedelic-assisted sessions. Its services appear to include direct patient care through clinic locations in Ontario as well as education and certification programming for registered clinicians. In September 2022, MindSetting Institute was acquired by Optimind Pharma, which positioned the business as part of a broader psychedelic-enhanced psychotherapy strategy. The company is best characterized as a healthcare services and training organization rather than a traditional drug-development biotech.